2,176 results match your criteria: "Big Data Institute[Affiliation]"
Nat Genet
November 2024
Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
PLoS One
October 2024
School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Background: Maternal preconception and pregnancy exposures have been linked to offspring adiposity. We aimed to quantify the effect of changes in maternal weight and smoking status between pregnancies on childhood overweight/obesity (≥ 85th centile) and obesity (≥ 95th centile) rates in second children.
Methods: Records for 5612 women were drawn from a population-based cohort of routinely collected antenatal healthcare records (2003-2014) linked to measured child body mass index (BMI) age 4-5 years.
medRxiv
August 2024
Nuffield Department of Population Health, University of Oxford, UK.
Importance: Higher physical activity levels have been suggested as a potential modifiable risk factor for lowering the risk of incident Parkinson's disease (PD). This study uses objective measures of physical activity to investigate the role of reverse causation in the observed association.
Objective: To investigate the association between accelerometer-derived daily step count and incident PD, and to assess the impact of reverse causation on this association.
NPJ Antimicrob Resist
September 2024
MRC Centre for Global Disease Analysis, Imperial College London, London, UK.
is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to elucidate the temporal and geographic epidemiology of drug-resistant within the UK. We analysed a representative sample of over 200 isolates from multiple UK hospitals to assess the number and timings of introductions and infer subsequent patterns of inter- and intra-hospital transmission of azole drug-resistant isolates.
View Article and Find Full Text PDFCancer Res Commun
October 2024
Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.
Mult Scler
October 2024
Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Background: The long-term disease trajectory of people living with multiple sclerosis (MS) can be improved by initiating efficacious treatment early. More quantitative evidence is needed on factors that affect a patient's risk of disability worsening or possibility of improvement to inform timely treatment decisions.
Methods: We developed a multistate model to quantify the influence of demographic, clinical, and imaging factors on disability worsening and disability improvement simultaneously across the disability spectrum as measured by the Expanded Disability Status Scale (EDSS).
Antibiotics (Basel)
September 2024
Department of Genomics, Institute of Biomedicine & Pharmacy (IBP), Vietnam Military Medical University, Hanoi 10000, Vietnam.
(1) Background: Pediatric urinary tract infections (UTIs) pose significant challenges due to drug-resistant () strains. This study utilizes whole-genome sequencing to analyze temporal trends in antibiotic resistance genes (ARGs) in clinical isolates from pediatric UTI cases in central Vietnam. (2) Methods: We conducted whole-genome sequencing on 71 isolates collected from pediatric UTI patients between 2018 and 2020.
View Article and Find Full Text PDFHIV Med
December 2024
Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.
Int J Biometeorol
December 2024
Big Data Institute, University of Oxford, Oxford, OX3 7LF, UK.
Brazilian livestock provides a significant fraction of the food consumed globally, making the country one of the largest producers and exporters of meat, milk and eggs. However, current advances in the production of protein from Brazilian animal origin may be directly impacted by climate change and the resulting biophysical effects. Therefore, it is strategically consistent to develop measures to deal with the resulting environmental heat stress on domesticated animal species, especially the need in developing countries.
View Article and Find Full Text PDFImaging Neurosci (Camb)
March 2024
Department of Psychology, Stanford University, Stanford, CA, United States.
NPJ Precis Oncol
September 2024
National Heart and Lung Institute, Imperial College London, London, UK.
Drug response prediction is hampered by uncertainty in the measures of response and selection of doses. In this study, we propose a probabilistic multi-output model to simultaneously predict all dose-responses and uncover their biomarkers. By describing the relationship between genomic features and chemical properties to every response at every dose, our multi-output Gaussian Process (MOGP) models enable assessment of drug efficacy using any dose-response metric.
View Article and Find Full Text PDFJ Infect
November 2024
Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR), Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Denmark; St
EClinicalMedicine
September 2024
Nottingham Centre for Public Health and Epidemiology, Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Background: Antimicrobial resistance (AMR) is a critical global health concern. A previous systematic review showed that migrants in Europe are at increased risk of AMR. Since the COVID-19 pandemic there have been rapid changes in patterns of antibiotic use, AMR, and migration.
View Article and Find Full Text PDFLab Chip
October 2024
Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PJ, UK.
Wellcome Open Res
October 2023
MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
J Infect
November 2024
Ineos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, United Kingdom. Electronic address:
Objectives: Integrating pathogen genomic surveillance with bioinformatics can enhance public health responses by identifying risk and guiding interventions. This study focusses on the two predominant Campylobacter species, which are commonly found in the gut of birds and mammals and often infect humans via contaminated food. Rising incidence and antimicrobial resistance (AMR) are a global concern, and there is an urgent need to quantify the main routes to human infection.
View Article and Find Full Text PDFGenet Med
December 2024
Big Data Institute, University of Oxford, United Kingdom; Wellcome Centre for Human Genetics, University of Oxford, United Kingdom; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA. Electronic address:
Purpose: Identifying pathogenic noncoding variants is challenging. A single protein-altering variant is often identified in a recessive gene in individuals with developmental disorders (DD), but the prevalence of pathogenic noncoding "second hits" in trans with these is unknown.
Methods: In 4073 genetically undiagnosed rare-disease trio probands from the 100,000 Genomes project, we identified rare heterozygous protein-altering variants in recessive DD-associated genes.
Neuropsychopharmacology
November 2024
Laureate Institute for Brain Research, Tulsa, OK, USA.
Neuroimaging plays a crucial role in understanding brain structure and function, but the lack of transparency, reproducibility, and reliability of findings is a significant obstacle for the field. To address these challenges, there are ongoing efforts to develop reporting checklists for neuroimaging studies to improve the reporting of fundamental aspects of study design and execution. In this review, we first define what we mean by a neuroimaging reporting checklist and then discuss how a reporting checklist can be developed and implemented.
View Article and Find Full Text PDFJ Sport Health Sci
September 2024
Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester LE5 4PW, UK; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), University Hospitals of Leicester National Health Service (NHS) Trust and the University of Leicester, Leice
Background: Higher accelerometer-assessed volume and intensity of physical activity (PA) have been associated with a longer life expectancy but can be difficult to translate into recommended doses of PA. We aimed to: (a) improve interpretability by producing UK Biobank age-referenced centiles for PA volume and intensity; (b) inform public-health messaging by examining how adding recommended quantities of moderate and vigorous PA affect PA volume and intensity.
Methods: 92,480 UK Biobank participants aged 43-80 years with wrist-worn accelerometer data were included.
iScience
September 2024
AMROMICS JSC, Vinh, Nghe An, Vietnam.
Machine learning has the potential to be a powerful tool in the fight against antimicrobial resistance (AMR), a critical global health issue. Machine learning can identify resistance mechanisms from DNA sequence data without prior knowledge. The first step in building a machine learning model is a feature extraction from sequencing data.
View Article and Find Full Text PDFAging Cell
December 2024
Translational Biogerontology Lab, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
The accumulation of senescent cells is thought to play a crucial role in aging-associated physiological decline and the pathogenesis of various age-related pathologies. Targeting senescence-associated cell surface molecules through immunotherapy emerges as a promising avenue for the selective removal of these cells. Despite its potential, a thorough characterization of senescence-specific surface proteins remains to be achieved.
View Article and Find Full Text PDFJ Med Genet
September 2024
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
Background: The 2015 American College of Medical Genetics/Association of Molecular Pathology (ACMG/AMP) variant classification framework specifies that case-control observations can be scored as 'strong' evidence (PS4) towards pathogenicity.
Methods: We developed the PS4-likelihood ratio calculator (PS4-LRCalc) for quantitative evidence assignment based on the observed variant frequencies in cases and controls. Binomial likelihoods are computed for two models, each defined by prespecified OR thresholds.
J Am Coll Cardiol
August 2024
Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; The Nation
Circ Cardiovasc Qual Outcomes
February 2025
Center for Translational Cardiology and Pragmatic Randomized Trials (J.C., N.D.J., D.M., K.H.J., A.M.R.J., N.E.L., T.B.-S.), Copenhagen University Hospital, Herlev and Gentofte, Denmark.
Background: Influenza vaccination reduces the risk of adverse outcomes in patients with cardiovascular disease (CVD). We sought to evaluate whether the presence of CVD modified the relative effectiveness of the high-dose quadrivalent influenza vaccine (QIV-HD) versus standard-dose quadrivalent influenza vaccine (QIV-SD) in this prespecified analysis of the DANFLU-1 trial (Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine Versus Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting).
Methods: DANFLU-1 was a pragmatic, open-label, randomized feasibility trial of QIV-HD versus QIV-SD in adults aged 65 to 79 years during the 2021/2022 influenza season in Denmark.
Endoscopy
January 2025
Department of Gastroenterology, Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom of Great Britain and Northern Ireland.
Background: Post-endoscopy upper gastrointestinal cancer (PEUGIC) is an important key performance indicator for endoscopy quality. We examined variation in PEUGIC rates among endoscopy providers in England and explored associated factors.
Methods: The was a population-based, retrospective, case-control study, examining data from National Cancer Registration and Analysis Service and Hospital Episode Statistics databases for esophageal and gastric cancers diagnosed between 2009 and 2018 in England.